Stocktoria
Resonate Blends, Inc. KOAN
Resonate Blends, Inc. (KOAN) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2024 revenue was $1.9M at a -125.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Services · percentile among 1013 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| KOAN | Resonate Blends, Inc. | 4/9 | — | — | — |
| GXAI | GAXOS.AI INC. | 2/9 | — | — | — |
| SCDA | B-Scada, Inc. | 4/9 | -1.47 | — | — |
| AUID | authID Inc. | 3/9 | — | — | — |
| PLTS | Platinum Analytics Cayman Ltd | 1/9 | 3.44 | — | — |
| SVMB | Jingbo Technology, Inc. | 5/9 | -16.66 | — | — |
| SITS | SOUTHERN ITS INTERNATIONAL, INC. | 2/9 | — | — | — |
About Resonate Blends, Inc.
Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.
FAQ
Is KOAN financially healthy?
Resonate Blends, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does KOAN pay a dividend?
No, Resonate Blends, Inc. does not currently pay a dividend.
How profitable is KOAN?
In FY2024, Resonate Blends, Inc. had a net margin of -125.8%.
Is KOAN a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Resonate Blends, Inc.: a Piotroski F-score of 4/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.